Spero Therapeutics, Inc.
SPRO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,382 | -$1,700 | -$13,866 | -$20,888 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,048 | $714 | $1,556 | $1,503 |
| Change in WC | $22,886 | -$16,985 | $8,035 | -$4,284 |
| Other Non-Cash | $870 | $278 | $273 | $268 |
| Operating Cash Flow | $17,422 | -$17,693 | -$4,002 | -$23,401 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $17,422 | -$17,693 | -$4,002 | -$23,401 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $31,194 | $48,887 | $52,889 | $76,290 |
| End Cash | $48,616 | $31,194 | $48,887 | $52,889 |
| Free Cash Flow | $17,422 | -$17,693 | -$4,002 | -$23,401 |